The Congo Ebola Crisis: When the World Looks Away

In eastern Democratic Republic of Congo (DRC), thousands of families have buried loved ones without doctors, without medicines, and often without even the dignity of a safe funeral. Villages have watched Ebola spread faster than help could arrive. Clinics have been burned, nurses threatened, and health workers forced to flee as armed groups tightened their grip. Children have lost parents before they could even be tested. Behind every statistic lies a family that waited for a response that came too late. More than 11,000 confirmed infections and nearly 5,300 deaths have made the 2026 Bundibugyo Ebola outbreak the deadliest in the DRC's history and the world's second-largest Ebola epidemic after West Africa's 2014-16 crisis. Yet this tragedy is not simply the story of a virus. It is a test of whether the world truly believes that every human life carries equal value.

The outbreak exposes the uncomfortable truth that global health solidarity remains selective. The world has spent the past decade promising to "never again" repeat the failures of West Africa and the 2018-20 eastern Congo Ebola epidemic. Yet when the Bundibugyo virus emerged, surveillance systems were weaker, laboratories underfunded, and emergency financing slower than the rhetoric suggested. Genetic evidence indicates that transmission likely began months before the outbreak was officially recognised. Local laboratories, largely configured to detect the more common Zaire strain, had to send samples hundreds of kilometres away for confirmation, while the virus silently spread through conflict-ridden communities.

These failures were not accidental. They were the predictable consequences of political choices. Post-pandemic donor fatigue, reductions in development assistance, shrinking support for multilateral institutions, staffing cuts in global disease surveillance programmes, and declining commitments to international health cooperation steadily eroded the very architecture created after previous Ebola crises. Contact tracing reached only a fraction of exposed individuals during the outbreak's critical early stages, while billions of dollars announced by donor governments often remained trapped in bureaucratic pipelines long after infections had surged. Epidemics do not wait for funding approvals.

Conflict transformed these institutional weaknesses into a humanitarian catastrophe. The epidemic unfolded in territories scarred by decades of armed violence, including areas affected by M23 and other militias. Health facilities were attacked, treatment centres burned, humanitarian corridors disrupted, and entire communities displaced. Public health cannot succeed where governance collapses and insecurity prevents nurses, epidemiologists and aid workers from reaching patients. Ebola spread not only because of a dangerous virus but because conflict had already dismantled the conditions necessary for disease control.

The outbreak also exposes the political economy of neglected diseases. Unlike the Zaire strain, which benefited from years of vaccine research and licensed therapeutics, Bundibugyo entered this epidemic without an approved vaccine or targeted treatment. The explanation lies not merely in scientific complexity but in economic incentives. Pharmaceutical innovation follows profitable markets far more readily than humanitarian risks. Diseases concentrated in poorer regions rarely attract sustained investment, advance purchase commitments or commercial incentives until they threaten wealthier societies. Candidate vaccines and platform technologies accelerated only after thousands had already died, demonstrating once again that global research priorities too often follow headlines instead of human need.

The irony extends beyond public health. Eastern Congo supplies much of the cobalt, coltan and other critical minerals powering electric vehicles, smartphones and artificial intelligence. Global supply chains depend upon its resources, yet the communities living above those minerals often lack functioning laboratories, protective equipment and basic healthcare. Globalisation eagerly extracts Congo's wealth while investing far too little in the health systems that protect Congolese lives. Such asymmetry exposes not only economic inequality but a deeper hierarchy of whose lives command international urgency.

The contrast with COVID-19 is equally revealing. When wealthy countries faced an existential threat, unprecedented financial resources, accelerated vaccine development and emergency regulatory pathways transformed scientific possibilities within months. By comparison, Bundibugyo Ebola remained a neglected pathogen until the epidemic reached catastrophic proportions. Viruses may not discriminate, but international responses frequently do.

Yet portraying Congo solely as a victim would repeat another injustice. The first line of defence has been built not by foreign experts but by Congolese doctors, nurses, laboratory scientists, community volunteers and local leaders who have continued working despite insecurity, exhausted supplies and repeated attacks. Their courage demonstrates that Africa possesses expertise, leadership and resilience. What it lacks is a global system willing to invest in those capacities before catastrophe unfolds. Strengthening the Africa Centres for Disease Control and Prevention, expanding regional vaccine manufacturing, empowering African research institutions and financing community-based surveillance are investments in global health security, not acts of charity.

The crisis also reminds us that epidemics emerge from broader structural realities. Armed conflict, chronic poverty, environmental degradation, expanding mining activity, deforestation and increasing human-wildlife interaction continue to create conditions for repeated zoonotic spillovers. Biomedical innovation alone cannot compensate for fragile institutions and neglected development.

Every Ebola outbreak is described as a lesson. Yet lessons repeatedly ignored become deliberate political choices. Before the next epidemic emerges, governments must rapidly disburse pledged funding, finance vaccines and therapeutics for neglected pathogens, rebuild surveillance systems weakened by aid cuts, protect humanitarian access in conflict zones and place African institutions at the centre of preparedness. Global health solidarity cannot be measured by the generosity shown once television cameras arrive. It is measured by whether lives in Goma or Bunia are valued as highly as lives in London, New York or Berlin before an outbreak threatens international travel. Until preparedness is built on equal human worth rather than unequal geopolitical interest, every promise of "never again" will remain another slogan spoken over another mass grave.